Current Report Filing (8-k)
April 03 2023 - 04:11PM
Edgar (US Regulatory)
0000028823False00000288232023-03-282023-03-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of Earliest Event Reported): March 28,
2023
Diebold Nixdorf, Incorporated
(Exact name of registrant as specified in its charter)
__________________________________________________________
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ohio |
|
1-4879 |
|
34-0183970 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
50 Executive Parkway, P.O. Box 2520 |
|
|
|
|
Hudson, |
Ohio |
|
|
|
44236 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
Registrant's telephone number, including area code: (330)
490-4000
Not Applicable
Former name or former address, if changed since last
report
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to
Rule 425 under the Securities Act (17 CFR
230.425)
☐ Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading Symbol |
|
Name of each exchange on which registered |
Common shares, $1.25 per value per share |
|
DBD |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On March 28, 2023, the People and Compensation Committee (the
“Committee”) of the Board of Directors (the “Board”) of Diebold
Nixdorf, Incorporated (the “Company”) approved grants of long-term
deferred cash awards to the Company’s named executive officers as
part of the Company’s overall compensation program for its named
executive officers for 2023.
The long-term deferred cash awards for 2023 are being granted in
place of time-vested restricted share units (“RSUs”) that have been
granted under the Company’s executive compensation program in prior
years. The terms of the cash awards are generally consistent with
the terms of the Company’s prior RSU grants. In electing to grant
long-term deferred cash awards in 2023, the Committee, working
together with its compensation consultant, considered the
significant impact of the Company’s refinancing at the end of 2022,
compensation program designs employed by public companies that have
undertaken similar refinancings, and the Committee’s desire to
reduce the dilutive impact to shareholders of further equity grants
by the Company.
The three-year deferred cash awards provide for the payment of a
fixed amount of deferred cash in three equal, annual installments
with the first installment to be paid in March 2024. Generally, the
named executive officers will be required to be employed by the
Company on each payment date to receive a payment. The amount
payable to the Company’s executive leadership team over the entire
three-year deferral period will be approximately $4.1
million.
The foregoing description of the terms for the three-year deferred
cash grants is qualified in its entirety by reference to the Form
of Deferred Cash Award Agreement attached hereto as Exhibit 10.1,
which is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits
|
|
|
|
|
|
|
|
Exhibit Number
|
Description
|
|
|
|
|
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL
document)
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diebold Nixdorf, Incorporated |
April 3, 2023 |
By: |
/s/ Jonathan B. Leiken |
|
|
Name: |
Jonathan B. Leiken |
|
|
Title: |
Executive Vice President, Chief Legal Officer and
Secretary |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diebold Nixdorf (NYSE:DBD)
Historical Stock Chart
From Aug 2023 to Sep 2023
Diebold Nixdorf (NYSE:DBD)
Historical Stock Chart
From Sep 2022 to Sep 2023